In animal models of inflammatory skin disease, NPI 32,101 was shown to decrease inflammation and down-regulates the production of interleukin-12 (IL-12), tumor necrosis factor-alpha (TNF-α) involved in the pathogenesis of inflammatory bowel disease [8]. The gene discussed is TNF; the disease is inflammatory bowel disease.